Company News in the Life Science Industry

»

Reset 

ViCentra Announces Closing of a EUR10 Million Investment Round to Fund Its International Growth

UTRECHT, Netherlands, July 8, 2020 /PRNewswire/ -- ViCentra, the company behind Kaleido, the world's smallest and lightest insulin pump, announced the closing of a EUR10 million investment round.

Read more ››
By: PR Newswire Association LLC. - 08 Jul 2020

Endoluminal Suturing Devices Market Size Worth $103.8 Million by 2027: Grand View Research, Inc.

SAN FRANCISCO, July 8, 2020 /PRNewswire/ -- The global Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020

Patient Engagement Solutions Market Growth to be Driven by Increasing Utilization of Electronic Health Records for Patient-centric Care and Adoption of Mobile Health Devices: Radiant Insights, Inc.

SAN FRANCISCO, July 8, 2020 /PRNewswire/ -- The global patient... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020
Related companies:  Radiant Insights, Inc

Cariprazine Significantly Improved Negative Symptoms of Schizophrenia Based on Real Life Data from a New Observational Study by Gedeon Richter Plc

BUDAPEST, Hungary, July 8, 2020 /PRNewswire/ -- On 4-7 July 2020, during the 28th Annual Meeting of the European Psychiatric Association (EPA) - which was held virtually due to the COVID-19 pandemic situation - new analysis of cariprazine studies in negative symptoms of schizophrenia was... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020
Related companies:  Gedeon Richter USA, Inc.

BrainStorm Hosting KOL Webinar to Discuss NurOwn® Phase 2 Alzheimer's Disease Program

NEW YORK, July 8, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, is hosting a Key Opinion Leader (KOL) webinar on its Alzheimer's Disease (AD) program today at 8:15 AM Eastern Time. The Company... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020
Related companies:  BrainStorm Cell Therapeutics Inc.

Exact Sciences schedules annual meeting, second quarter 2020 earnings call

MADISON, Wis., July 8, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company has scheduled its virtual annual stockholders meeting and second quarter 2020 earnings call.

Read more ››
By: PR Newswire Association LLC. - 08 Jul 2020
Related companies:  Exact Sciences Corp.

Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe

NEW YORK and LONDON, July 8, 2020 /PRNewswire/ -- Today Aetion and Cegedim Health Data announced a new partnership... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020
Related companies:  Aetion, Inc.

Glucose Health, Inc. Amazon Sales for June Increase 1,284% YOY

BENTONVILLE, Arkansas, July 8, 2020 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) - the manufacturer of GLUCODOWN(®) - today advised that June 2020 sales at Amazon were $38,594.89 vs. June 2019 sales of $2,787.87 - a 1,284% increase demonstrating the tremendous growth the GLUCODOWN(®) brand... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020

Experts Outline Key Steps for Hospitals to Welcome Back Family Caregivers During COVID-19

OTTAWA, ON, July 8, 2020 /CNW/ - Today, the Canadian Foundation for Healthcare Improvement released a new report that outlines key steps and resources for hospitals to welcome back family caregivers. The report, Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020

89bio Announces Pricing of Upsized Public Offering of Common Stock

Read more ››
By: GlobenewsWire - 08 Jul 2020
Related companies:  89bio, Inc.

Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs

Read more ››
By: GlobenewsWire - 08 Jul 2020
Related companies:  Ascendis Pharma A/S

Vir Biotechnology Announces Pricing of Public Offering of Common Stock

Read more ››
By: GlobenewsWire - 08 Jul 2020
Related companies:  Vir Biotechnology, Inc.

Kiadis licenses previously undisclosed pre-clinical K-NK-cell programs to Sanofi, with total potential deal value of €875 million, plus royalties

Read more ››
By: GlobenewsWire - 08 Jul 2020
Related companies:  Kiadis Pharma N.V.

Barclays and Unreasonable Select 1mg Technologies to Receive $100,000 Grant in Support of COVID-19 Related Work

NEW DELHI, July 8, 2020 /PRNewswire/ -- 1mg Technologies has been awarded a $100,000 grant in recognition of the exceptional work being undertaken in addressing the immediate and long term challenges resulting from the effects of the global pandemic.

Read more ››
By: PR Newswire Association LLC. - 08 Jul 2020

Akero Therapeutics Announces Pricing of Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., July 7, 2020 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic non-alcoholic steatohepatitis (NASH) company developing pioneering medicines designed to restore metabolic balance and improve the overall health of NASH patients, announced today... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020
Related companies:  Akero Therapeutics, Inc.

Coronavirus (COVID-19) Update: Daily Roundup

SILVER SPRING, Md., July 7, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic:

Read more ››
By: PR Newswire Association LLC. - 08 Jul 2020
Related companies:  U.S. Food and Drug Administration

Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China

SHANGHAI, July 8, 2020 /PRNewswire/ -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, and Zai Lab (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020

Rapidly Changing Behaviours In 2020 Are Accelerating Consumer Embrace of Digital, Health, and Sustainability Trends, Says PwC

NEW YORK, July 7, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 08 Jul 2020

60% Are Willing to Risk Their Health To Vote In Person In November

MOUNTAIN VIEW, Calif., July 8, 2020 /PRNewswire/ -- Sacrificing one's health to vote in the November election: 60% are willing to risk their health to vote in person, according to the latest Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020

Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of  N-Nitrosodimethylamine (NDMA) Impurity

BALTIMORE, July 8, 2020 /PRNewswire/ -- Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA, additional analysis... Read more ››

By: PR Newswire Association LLC. - 08 Jul 2020
Related companies:  Lupin Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »

Explore our database of over 50,000 companies